Prestige BioPharma Limited (KRX: 950210)
South Korea flag South Korea · Delayed Price · Currency is KRW
14,700
-340 (-2.26%)
Dec 20, 2024, 10:52 AM KST

Prestige BioPharma Revenue

Prestige BioPharma had revenue of 2.22B KRW in the quarter ending September 30, 2024, with 3,199.98% growth. This brings the company's revenue in the last twelve months to 2.84B, up 1,140.77% year-over-year. In the fiscal year ending June 30, 2024, Prestige BioPharma had annual revenue of 689.08M with 325.77% growth.

Revenue (ttm)
2.84B
Revenue Growth
+1,140.77%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
173.08B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 2024689.08M527.23M325.77%
Jun 30, 2023161.84M--
Jun 30, 2022---
Jun 30, 2021---
Jun 30, 2020---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition